|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,738 INR | +3.87% |
|
+2.65% | +19.12% |
| 10/05 | Transcript : Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| 10/05 | Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4% | MT |
Hester Biosciences Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 878.53 million compared to INR 506.95 million a year ago. Revenue was INR 889.98 million compared to INR 538.18 million a year ago.
Net income was INR 58.69 million compared to INR 39.68 million a year ago. Basic earnings per share from continuing operations was INR 7.89 compared to INR 4.19 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.12% | 177M | |
| -14.35% | 77.13B | |
| +14.09% | 8.4B | |
| +27.62% | 3.79B | |
| -0.70% | 3.22B | |
| +14.70% | 1.64B | |
| -10.12% | 1.5B | |
| -22.60% | 1.3B | |
| -4.20% | 1.25B | |
| -10.26% | 1.18B |
HESTER BIOSCIENCES LIMITED 